As of April 18, 2025, Mainz Biomed (MYNZ) has a market cap of $7.154 million USD. According to our data, Mainz Biomed is ranked No.8910 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $7.15 M |
-25.46%
|
Dec 31, 2024 | $9.60 M |
272.41%
|
Dec 29, 2023 | $2.58 M |
-83.66%
|
Dec 30, 2022 | $15.77 M |
-31.67%
|
Dec 31, 2021 | $23.08 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Exact Sciences
EXAS
|
$7.72 B |
-0.000 M
|
![]() USA
|
![]() Guardant Health
GH
|
$5.55 B |
-0.000 M
|
![]() USA
|
![]() Natera
NTRA
|
$20.02 B |
0.001 M
|
![]() USA
|
![]() Fulgent Genetics
FLGT
|
$0.55 B |
0.000 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.23 B |
0.000 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() Adaptive Biotechnologies
ADPT
|
$1.09 B |
0.000 M
|
![]() USA
|
![]() Illumina
ILMN
|
$11.27 B |
-0.000 M
|
![]() USA
|
![]() QuidelOrtho
QDEL
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Hologic
HOLX
|
$12.99 B |
-0.000 M
|
![]() USA
|
![]() Qiagen
QGEN
|
$8.80 B |
-0.000 M
|
![]() Netherlands
|
![]() Becton Dickinson
BDX
|
$57.06 B |
0.001 M
|
![]() USA
|
Market Cap | = | MYNZ Stock Price | * | MYNZ Shares Outstanding |
= | $3.22 | * | 2.22 M | |
= | $7.15 M |